These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

699 related articles for article (PubMed ID: 24415445)

  • 1. Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage.
    Seo YS; Park SY; Kim MY; Kim JH; Park JY; Yim HJ; Jang BK; Kim HS; Hahn T; Kim BI; Heo J; An H; Tak WY; Baik SK; Han KH; Hwang JS; Park SH; Cho M; Um SH
    Hepatology; 2014 Sep; 60(3):954-63. PubMed ID: 24415445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with endoscopic band ligation: a randomized double-blind placebo-controlled trial.
    Abid S; Jafri W; Hamid S; Salih M; Azam Z; Mumtaz K; Shah HA; Abbas Z
    Am J Gastroenterol; 2009 Mar; 104(3):617-23. PubMed ID: 19223890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of terlipressin and octreotide with variceal ligation for controlling acute esophageal variceal bleeding--a randomized prospective study].
    Cho SB; Park KJ; Lee JS; Lee WS; Park CH; Joo YE; Kim HS; Choi SK; Rew JS; Kim SJ
    Korean J Hepatol; 2006 Sep; 12(3):385-93. PubMed ID: 16998290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A prospective study comparing the efficacy of early administration of terlipressin and somatostatin for the control of acute variceal bleeding in patients with cirrhosis].
    Seo YS; Um SH; Hyun JJ; Kim YH; Park S; Keum BR; Kim YS; Jeen YT; Lee HS; Chun HJ; Lee SW; Choi JH; Kim CD; Ryu HS
    Korean J Hepatol; 2006 Sep; 12(3):373-84. PubMed ID: 16998289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin, somatostatin analogues and other vasoactive drugs in the treatment of bleeding oesophageal varices.
    de Franchis R
    Dig Liver Dis; 2004 Feb; 36 Suppl 1():S93-100. PubMed ID: 15077917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No mortality difference following treatment with terlipressin or somatostatin in cirrhotic patients with gastric variceal hemorrhage.
    Hung TH; Tsai CC; TsenK GC; Hsieh YH; Tseng CW
    Saudi J Gastroenterol; 2016; 22(3):220-5. PubMed ID: 27184641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of vasopressin/terlipressin and somatostatin/octreotide for the prevention of early variceal rebleeding after the initial control of bleeding: a systematic review and meta-analysis.
    Wang C; Han J; Xiao L; Jin CE; Li DJ; Yang Z
    Hepatol Int; 2015 Jan; 9(1):120-9. PubMed ID: 25788386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis.
    D'Amico G; Pietrosi G; Tarantino I; Pagliaro L
    Gastroenterology; 2003 May; 124(5):1277-91. PubMed ID: 12730868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug therapy of hemorrhage in esophageal and gastric varices: role of vasoactive drugs].
    Pulanić R
    Lijec Vjesn; 2000; 122(11-12):276-83. PubMed ID: 11291271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: a critical comparison of drug therapies in currently used therapeutic strategies for variceal haemorrhage.
    Nevens F
    Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():18-22; discussion 23. PubMed ID: 15335394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terlipressin for acute esophageal variceal hemorrhage.
    Ioannou G; Doust J; Rockey DC
    Cochrane Database Syst Rev; 2003; (1):CD002147. PubMed ID: 12535432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terlipressin for acute esophageal variceal hemorrhage.
    Ioannou G; Doust J; Rockey DC
    Cochrane Database Syst Rev; 2001; 2003(1):CD002147. PubMed ID: 11279753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of variceal pressure by continuous non-invasive endoscopic registration: a placebo controlled evaluation of the effect of terlipressin and octreotide.
    Nevens F; Van Steenbergen W; Yap SH; Fevery J
    Gut; 1996 Jan; 38(1):129-34. PubMed ID: 8566840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical management of variceal bleeding in patients with cirrhosis.
    Abraldes JG; Dell'Era A; Bosch J
    Can J Gastroenterol; 2004 Feb; 18(2):109-13. PubMed ID: 14997222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approach to the management of bleeding esophageal varices: role of somatostatin.
    Avgerinos A
    Digestion; 1998; 59 Suppl 1():1-22. PubMed ID: 9603441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergency sclerotherapy versus vasoactive drugs for bleeding oesophageal varices in cirrhotic patients.
    D'Amico G; Pagliaro L; Pietrosi G; Tarantino I
    Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD002233. PubMed ID: 20238318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled trial of ligation plus vasoconstrictor versus proton pump inhibitor in the control of acute esophageal variceal bleeding.
    Lo GH; Perng DS; Chang CY; Tai CM; Wang HM; Lin HC
    J Gastroenterol Hepatol; 2013 Apr; 28(4):684-9. PubMed ID: 23278466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No difference in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding and renal functional impairment.
    Hung TH; Tsai CC; Tseng CW; Tseng KC; Hsieh YH; Tsai CC
    Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1275-9. PubMed ID: 27455080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome.
    Krag A; Borup T; Møller S; Bendtsen F
    Adv Ther; 2008 Nov; 25(11):1105-40. PubMed ID: 19018483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of splanchnic vasoconstrictors and endoscopic band ligation is an effective treatment strategy for acute variceal hemorrhage; but how do we get those drugs approved by the FDA?
    Fortune BE; Groszmann RJ
    Hepatology; 2014 Sep; 60(3):789-91. PubMed ID: 24700393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 35.